Viridium Pacific Group Ltd.: Experion Launches ‘Citizen Stash’ Brand for Canada’s Recreational Cannabis Market

Biotech & MedTech, Food, Health & Wellness

December 18, 2018 (Source) — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce that Experion Biotechnologies Inc. (“Experion”), a wholly owned subsidiary licensed under the Cannabis Act, has launched its first adult-use cannabis brand, Citizen Stash. During the O’Cannabiz Conference & Expo, which took place December 9 to 11, 2018 in Vancouver, British Columbia, the Citizen Stash brand was introduced. The brand was created to appeal to those seeking recreational cannabis in Canada’s recently legalized market.

Citizen Stash cannabis products will be hand cultivated in Experion’s indoor facility in Mission, British Columbia to the highest standards to ensure quality and exceptional user experience Although Experion has not set a firm launch date, the Company is aiming to market and have available for sale its first Citizen Stash product in the first quarter of 2019.

“Citizen Stash is about coming together. We want Citizen Stash to be a brand that is all about celebrating our collective experience as Canadians. Our efforts with regard to finalizing supply agreements for the recreational markets in BC and Saskatchewan are progressing well, which means that we are getting excited about shipping our first Citizen Stash product,” stated Jay Garnett, Viridium President and Chief Executive Officer. “We will be supporting the launch of Citizen Stash through our web and social media efforts, and brand activities and experiences.”

Corporate Note

Further to the Company’s news release of March 16, 2018 announcing, amongst other things, the resignation of Steve Serenas, the Company advises that notwithstanding its best efforts, it has been unable to come to a final understanding with Mr. Serenas on his terminal compensation package even though it was agreed to following his resignation. Similarly, upon Chris McArthur’s departure from the Company, as announced May 7, 2018, the Company has had ongoing discussions with him on his terminal compensation package but no agreement has yet been reached.

About Viridium

Viridium Pacific Group Ltd. is a consumer wellness and biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production, (Experion Biotechologies Inc.) property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.) Experion Biotechnologies Inc., is a Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.

More information about Viridium can be found under the Company’s profile on SEDAR at


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at